Compare Johnson Controls International PLC (JCI) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs Tempus AI — how do they compare? Johnson Controls International PLC trades at $155.13 (market cap $93.28B), while Tempus AI trades at $69.85 (market cap $12.58B). The key difference: Johnson Controls International PLC is far larger — about 7.4× Tempus AI's market cap, and Johnson Controls International PLC pays a 1.04% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson Controls International PLC for 65 Days and Tempus AI for 22 Days on average.
| JCI | TEM | |
|---|---|---|
Market Cap | $93.28B | $12.58B |
Volume | 2,786,476 | 7,444,569 |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $158.76 | $99.28 |
52-Week Low | $105.55 | $41.55 |
Typical Hold Time | 65 Days | 22 Days |
Enterprise Value | $102.12B | $13.21B |
Dividend Yield | 1.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson Controls International (JCI) trades at $155.93, down 1.78% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with an EPS of $1.42, and raised its full-year 2026 guidance. Revenue for 2025 was $23.60B, with net income surging to $3.29B, reflecting a robust profit margin of 13.94%. Analyst sentiment is positive, with a consensus price target of $172.50 and no sell ratings among 45 analysts.
The outlook for JCI is favorable, driven by strong demand in data-center and mission-critical thermal management systems, as highlighted in recent earnings. Investment opportunities include potential upside to the consensus target and consistent dividend payments. Key risks involve elevated valuation multiples, such as a P/E of 43.92, and macroeconomic sensitivity impacting industrial demand.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
